Market Overview:
The global medical sodium hyaluronate gel market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for sodium hyaluronate gel in various applications such as biomedicine, biomaterials and functional food. North America is expected to dominate the global medical sodium hyaluronate gel market during the forecast period owing to the presence of key players and technological advancements in this region.
Product Definition:
Medical Sodium Hyaluronate Gel is a transparent gel that is used as a lubricant and to help protect the eye during surgery.
2ml:
2ml, it’s usage and growth factor in medical sodium hyaluronate gel market is driven by the increasing demand for minimally invasive surgical procedures coupled with technological advancements. The 2ml Sodium Hyaluronate (SH) injectable has been around for quite some time. It was first approved by the U.S Food and Drug Administration (FDA) back in 1991 as a treatment for knee pain following an injury or surgery to the ligaments of the knee.
2.5ml:
2.5ml is a volume unit used for measuring the concentration of medical sodium hyaluronate gel, which is an injectable drug used to treat joint pain and reduce inflammation. It works by increasing the water content in connective tissues such as cartilage and bone, hence reducing pain.
Application Insights:
Medical sodium hyaluronate gel finds applications in various fields including biomedicine, biomaterials, and food. The biomaterials segment held the largest market share of over 40% in 2017. This is due to its increasing use as a replacement for de-natured or crude proteins and other polysaccharides such as collagen and chondroitin sulfate. It is extensively used in surgical masks, dressings & bandages, artificial ligaments & tendons owing to its excellent wound healing properties.
Hyaluronan has been studied thoroughly during the past few years with respect to its ability to prevent diseases by strengthening immunity against bacteria and viruses through humoral (IgA) and cell-mediated immune responses along with providing passive immunity against infections caused by bacteria that have attacked the body tissues or organs via blood stream or respiratory tract.
Regional Analysis:
North America was the largest regional market in 2017 owing to the presence of a large number of players and well-established healthcare infrastructure. The region is expected to maintain its dominance during the forecast period due to increasing applications in various medical fields such as wound dressing, eye drop, joint pain & arthritis, sports injuries & postoperative care. In addition, rising prevalence of chronic diseases such as diabetes and osteoarthritis is anticipated to boost product demand over the forecast period.
Asia Pacific is estimated to be one of the fastest growing regions during 2018 - 2030 due to factors such as improving healthcare facilities along with an increase in disposable income level among patients suffering from chronic disorders that require long term treatment with sodium hyaluronate gel products. Moreover, growing awareness regarding advanced therapies for treating joint related problems will drive growth further.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global medical sodium hyaluronate gel market is expected to benefit from the increasing demand for minimally invasive surgeries. This is because the use of medical sodium hyaluronate gel helps in reducing tissue trauma and inflammation during these procedures.
- Rising prevalence of chronic diseases: The global medical sodium hyaluronate gel market is also expected to benefit from the rising prevalence of chronic diseases such as arthritis, osteoarthritis, and others. This is because the use of medical sodium hyaluronate gel helps in providing relief from pain and other symptoms associated with these conditions.
- Growing geriatric population: The global medical sodium hyaluronate gel market is also expected to benefit from the growing geriatric population across the world. This is because as people age, they are more likely to suffer from conditions that can be treated with medical sodium hyaluronate gels such as joint pain, arthritis, etcetera .
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Sodium Hyaluronate Gel Market Research Report
By Type
2ml, 2.5ml, 3ml, 5ml, 17ml
By Application
Biomedicine, Biomaterials, Functional Food
By Companies
Bausch & Lomb-Freda, Adhesion Biomedical, Bostik Ltd., Henkel AG & Company, B. Braun Melsungen, CryoLife, Inc., Itac Ltd., Ethicon Inc., Chemence Ltd., Covidien Ltd., Bausch & Lomb-Freda, Cyberbond LLC, Baxter International Inc., GEM S.r.l, Meyer-Haake Gmbh, Biocoral, Inc, Scapa Healthcare, Lohmann GmbH, Mercator Medical, Altergon, Haohai Biological Technology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
205
Number of Tables & Figures
144
Customization Available
Yes, the report can be customized as per your need.
Global Medical Sodium Hyaluronate Gel Market Report Segments:
The global Medical Sodium Hyaluronate Gel market is segmented on the basis of:
Types
2ml, 2.5ml, 3ml, 5ml, 17ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biomedicine, Biomaterials, Functional Food
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bausch & Lomb-Freda
- Adhesion Biomedical
- Bostik Ltd.
- Henkel AG & Company
- B. Braun Melsungen
- CryoLife, Inc.
- Itac Ltd.
- Ethicon Inc.
- Chemence Ltd.
- Covidien Ltd.
- Bausch & Lomb-Freda
- Cyberbond LLC
- Baxter International Inc.
- GEM S.r.l
- Meyer-Haake Gmbh
- Biocoral, Inc
- Scapa Healthcare
- Lohmann GmbH
- Mercator Medical
- Altergon
- Haohai Biological Technology
Highlights of The Medical Sodium Hyaluronate Gel Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 2ml
- 2.5ml
- 3ml
- 5ml
- 17ml
- By Application:
- Biomedicine
- Biomaterials
- Functional Food
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Sodium Hyaluronate Gel Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical sodium hyaluronate gel is a type of topical medication that is used to treat various skin conditions. It works by helping to restore the moisture and elasticity in the skin. This can help improve the appearance of scars, wrinkles, and other signs of aging.
Some of the major companies in the medical sodium hyaluronate gel market are Bausch & Lomb-Freda, Adhesion Biomedical, Bostik Ltd., Henkel AG & Company, B. Braun Melsungen, CryoLife, Inc., Itac Ltd., Ethicon Inc., Chemence Ltd., Covidien Ltd., Bausch & Lomb-Freda, Cyberbond LLC, Baxter International Inc., GEM S.r.l, Meyer-Haake Gmbh, Biocoral, Inc, Scapa Healthcare, Lohmann GmbH, Mercator Medical, Altergon, Haohai Biological Technology.
The medical sodium hyaluronate gel market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Medical Sodium Hyaluronate Gel Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Medical Sodium Hyaluronate Gel Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Medical Sodium Hyaluronate Gel Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Medical Sodium Hyaluronate Gel Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Medical Sodium Hyaluronate Gel Market Size & Forecast, 2018-2028
4.5.1 Medical Sodium Hyaluronate Gel Market Size and Y-o-Y Growth
4.5.2 Medical Sodium Hyaluronate Gel Market Absolute $ Opportunity
Chapter 5 Global Medical Sodium Hyaluronate Gel Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Medical Sodium Hyaluronate Gel Market Size Forecast by Type
5.2.1 2ml
5.2.2 2.5ml
5.2.3 3ml
5.2.4 5ml
5.2.5 17ml
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Medical Sodium Hyaluronate Gel Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Medical Sodium Hyaluronate Gel Market Size Forecast by Applications
6.2.1 Biomedicine
6.2.2 Biomaterials
6.2.3 Functional Food
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Medical Sodium Hyaluronate Gel Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Medical Sodium Hyaluronate Gel Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Medical Sodium Hyaluronate Gel Analysis and Forecast
9.1 Introduction
9.2 North America Medical Sodium Hyaluronate Gel Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Medical Sodium Hyaluronate Gel Market Size Forecast by Type
9.6.1 2ml
9.6.2 2.5ml
9.6.3 3ml
9.6.4 5ml
9.6.5 17ml
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Medical Sodium Hyaluronate Gel Market Size Forecast by Applications
9.10.1 Biomedicine
9.10.2 Biomaterials
9.10.3 Functional Food
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Medical Sodium Hyaluronate Gel Analysis and Forecast
10.1 Introduction
10.2 Europe Medical Sodium Hyaluronate Gel Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Medical Sodium Hyaluronate Gel Market Size Forecast by Type
10.6.1 2ml
10.6.2 2.5ml
10.6.3 3ml
10.6.4 5ml
10.6.5 17ml
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Medical Sodium Hyaluronate Gel Market Size Forecast by Applications
10.10.1 Biomedicine
10.10.2 Biomaterials
10.10.3 Functional Food
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Medical Sodium Hyaluronate Gel Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Medical Sodium Hyaluronate Gel Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Medical Sodium Hyaluronate Gel Market Size Forecast by Type
11.6.1 2ml
11.6.2 2.5ml
11.6.3 3ml
11.6.4 5ml
11.6.5 17ml
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Medical Sodium Hyaluronate Gel Market Size Forecast by Applications
11.10.1 Biomedicine
11.10.2 Biomaterials
11.10.3 Functional Food
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Medical Sodium Hyaluronate Gel Analysis and Forecast
12.1 Introduction
12.2 Latin America Medical Sodium Hyaluronate Gel Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Medical Sodium Hyaluronate Gel Market Size Forecast by Type
12.6.1 2ml
12.6.2 2.5ml
12.6.3 3ml
12.6.4 5ml
12.6.5 17ml
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Medical Sodium Hyaluronate Gel Market Size Forecast by Applications
12.10.1 Biomedicine
12.10.2 Biomaterials
12.10.3 Functional Food
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Medical Sodium Hyaluronate Gel Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Medical Sodium Hyaluronate Gel Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Medical Sodium Hyaluronate Gel Market Size Forecast by Type
13.6.1 2ml
13.6.2 2.5ml
13.6.3 3ml
13.6.4 5ml
13.6.5 17ml
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Medical Sodium Hyaluronate Gel Market Size Forecast by Applications
13.10.1 Biomedicine
13.10.2 Biomaterials
13.10.3 Functional Food
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Medical Sodium Hyaluronate Gel Market: Competitive Dashboard
14.2 Global Medical Sodium Hyaluronate Gel Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bausch & Lomb-Freda
14.3.2 Adhesion Biomedical
14.3.3 Bostik Ltd.
14.3.4 Henkel AG & Company
14.3.5 B. Braun Melsungen
14.3.6 CryoLife, Inc.
14.3.7 Itac Ltd.
14.3.8 Ethicon Inc.
14.3.9 Chemence Ltd.
14.3.10 Covidien Ltd.
14.3.11 Bausch & Lomb-Freda
14.3.12 Cyberbond LLC
14.3.13 Baxter International Inc.
14.3.14 GEM S.r.l
14.3.15 Meyer-Haake Gmbh
14.3.16 Biocoral, Inc
14.3.17 Scapa Healthcare
14.3.18 Lohmann GmbH
14.3.19 Mercator Medical
14.3.20 Altergon
14.3.21 Haohai Biological Technology
